SGBHD Stock Overview
An investment holding company, provides integrated turnkey solutions for the development of cleanrooms used in laboratories and medical centers in Malaysia.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Supergenics Berhad Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | RM 0.60 |
| 52 Week High | RM 0.60 |
| 52 Week Low | RM 0.23 |
| Beta | 0.10 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 114.29% |
Recent News & Updates
Recent updates
Shareholder Returns
| SGBHD | MY Construction | MY Market | |
|---|---|---|---|
| 7D | 0% | -4.3% | -1.6% |
| 1Y | n/a | 66.3% | 16.1% |
Return vs Industry: Insufficient data to determine how SGBHD performed against the MY Construction industry.
Return vs Market: Insufficient data to determine how SGBHD performed against the MY Market.
Price Volatility
| SGBHD volatility | |
|---|---|
| SGBHD Average Weekly Movement | n/a |
| Construction Industry Average Movement | 7.6% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in MY Market | 11.7% |
| 10% least volatile stocks in MY Market | 2.4% |
Stable Share Price: SGBHD has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine SGBHD's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1982 | n/a | Bii Chau Tan | www.supergenic.com.my |
Supergenics Berhad, an investment holding company, provides integrated turnkey solutions for the development of cleanrooms used in laboratories and medical centers in Malaysia. The company is involved in the provision of administrative health care services; and operation of medical laboratories; and development of medical treatment and wellness products. It also offers technology and manufacturing system development services for cell, gene, and tissue therapies; and management services for cleanrooms.
Supergenics Berhad Fundamentals Summary
| SGBHD fundamental statistics | |
|---|---|
| Market cap | RM 69.41m |
| Earnings (TTM) | RM 176.86k |
| Revenue (TTM) | RM 10.24m |
392.5x
P/E Ratio6.8x
P/S RatioIs SGBHD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SGBHD income statement (TTM) | |
|---|---|
| Revenue | RM 10.24m |
| Cost of Revenue | RM 5.59m |
| Gross Profit | RM 4.65m |
| Other Expenses | RM 4.47m |
| Earnings | RM 176.86k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.0015 |
| Gross Margin | 45.41% |
| Net Profit Margin | 1.73% |
| Debt/Equity Ratio | 39.4% |
How did SGBHD perform over the long term?
See historical performance and comparison